The study investigates the effects of Ginkgo biloba extract (EGb 761) on cognitive deficits in a mouse model of Alzheimer’s disease. The findings revealed that EGb 761 administration enhanced memory performance, increased the proliferation of new neurons in the hippocampus, and reduced amyloid-beta (Aβ) accumulation, suggesting its potential therapeutic role in mitigating Alzheimer’s-related cognitive decline.